Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$35,740,429
+$6,440,394 QoQ
Shares Held
142,030
+5.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#440
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. ABBV ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,662 | $64,363,817 | |
| 2 | JNJ |
Johnson & Johnson
|
201,691 | $51,223,462 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
142,030 | $35,740,429 | |
| 4 | MRK |
Merck & Co., Inc.
|
201,987 | $25,955,329 | |
| 5 | AMGN |
Amgen Inc
|
42,764 | $15,485,699 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
74,929 | $9,466,529 | |
| 7 | PFE |
Pfizer Inc
|
365,411 | $8,799,096 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
134,318 | $7,739,403 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,740,429 | 142,030 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $29,300,035 | 134,719 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $31,418,517 | 137,505 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,291,936 | 135,147 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,326,920 | 136,445 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $25,828,367 | 123,274 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $20,136,075 | 113,315 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,458,575 | 83,343 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $11,815,326 | 68,886 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $10,015,317 | 54,999 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,799,020 | 50,326 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,223,640 | 55,170 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,315,300 | 54,296 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $10,704,723 | 67,169 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $10,256,417 | 63,464 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,456,841 | 55,561 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $11,183,590 | 73,019 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $7,472,946 | 46,098 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $6,958,612 | 51,393 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $4,776,483 | 44,280 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $3,999,508 | 35,507 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $3,356,226 | 31,013 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,235,822 | 30,199 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,668,166 | 30,462 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,876,379 | 29,297 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,109,624 | 27,689 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||